Agonist derived molecular probes for A2 adenosine receptors
- 1 December 1989
- journal article
- research article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 2 (4) , 170-178
- https://doi.org/10.1002/jmr.300020406
Abstract
The adenosine agonist 2‐(4‐(2‐carboxyethyl)phenylethylamino)‐5′‐N‐ethylcarboxamidoadenosine (CGS21680) was recently reported to be selective for the A2 adenosine receptor subtype, which mediates its hypotensive action. To investigate structure/activity relationships at a distal site, CGS21680 was derivatized using a functionalized congener approach. The carboxylic group of CGS21680 has been esterified to form a methyl ester, which was then treated with ethylenediamine to produce an amine congener. The amine congener was an intermediate for acylation reactions, in which the reactive acyl species contained a reported group, or the precursor for such. For radioiodination, derivatives of p‐hydroxyphenylpropionic, 2‐thiophenylacetic, and p‐aminophenylacetic acids were prepared. The latter derivative (PAPA‐APEC) was iodinated electrophilically using [125I]iodide resulting in a radioligand which was used for studies of competition of binding to striatal A2 adenosine receptors in bovine brain. A biotin conjugate and an aryl sulfonate were at least 350‐fold selective for A2 receptors. For spectroscopic detection, a derivative of the stable free radical tetramethyl‐1‐piperidinyloxy (TEMPO) was prepared. For irreversible inhibition of receptors, meta‐ and para‐phenylenediisothiocyanate groups were incorporated in the analogs. We have demonstrated that binding at A2 receptors is relatively insensitive to distal structural changes at the 2‐position, and we report high affinity molecular probes for receptor characterization by radioactive, spectroscopic and affinity lebelling methodology.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of the A1 Adenosine Receptor-Adenylate Cyclase System of Cerebral Cortex Using an Agonist Photoaffinity LigandJournal of Neurochemistry, 2006
- 2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligandsJournal of Medicinal Chemistry, 1990
- N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptorJournal of Medicinal Chemistry, 1988
- Iodine-125-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptorsJournal of Medicinal Chemistry, 1988
- N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activityJournal of Medicinal Chemistry, 1987
- Purine Receptors in Mammalian Tissues: Pharmacology and Functional SignificanceAnnual Review of Pharmacology and Toxicology, 1987
- N6-Substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptorsJournal of Medicinal Chemistry, 1986
- Californium-252 plasma desorption mass spectrometry as an aid in the synthesis of a series of adenosine and xanthine conjugatesJournal of the Chemical Society, Perkin Transactions 1, 1986
- Identification of α-Adrenergic Receptors in Human Platelets by [3H]Dihydroergocryptine BindingJournal of Clinical Investigation, 1978
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973